arrow
B

Bishoy M. Faltas

Weill Cornell Medicine
H指数:39
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities

患者来源的类器官跨越癌症揭示了保守的肿瘤异质性和可操作的药物治疗易感性

2026-06-260
OA
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies

通过多参数药物筛选鉴定的9p21缺失所揭示的治疗易感位点为理性联合策略提供信息

2026-04-180
OAAI
International Society of Urological Pathology Consensus Meeting 2024

国际泌尿病理学会共识会议2024

2025-12-010
PRE
HER2 and urothelial carcinoma: current understanding and future directions

HER2与尿路上皮癌:当前认知与未来方向

2025-08-150
PRE
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling

全基因组规模的纠错型流式测序及其在循环游离DNA分析中的应用

2025-04-110
PRE
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution
Nature
IF48.5
2024-10-090
OAAI
Balanced-strand sequencing for highly efficient duplex variant calling in circulating tumor DNA
2024-03-220
PRE
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis
2024-03-181
OAAI
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma

循环肿瘤DNA鉴别肌肉浸润性和非器官限制的上尿路尿路上皮癌的新用途

2024-03-018
PRE
Common germline-somatic variant interactions in advanced urothelial cancer
2020-12-0320
OAAI
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study

晚期尿路上皮癌循环肿瘤DNA改变及其与临床预后的关系: 一项初步研究

2020-10-0128
PREAI